Cell density-dependent regulation of mdr-1 gene expression in murine colon cancer cells

International Journal of Oncology

Volumn 9, Issue 5, 1996, Pages 865-878

  Fan, Dominic ^a   Beltran, Pedro J ^a   Wang, Yun Fang ^a   Bucana, Corazon D ^a   Yoon, Sung Soo ^a   Deguzman, Ariel Caesar P ^a   Fidler, Isaiah J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

cell density; mdr 1; P glycoprotein; regulation

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; MESSENGER RNA; VINBLASTINE;

ANIMAL CELL; ARTICLE; CELL DENSITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG SENSITIVITY; GENE EXPRESSION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029857643     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.5.865     Document Type: Article

References (74)

1. Kartner N, Riordan JR and Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221: 1285-1288, 1983.
2. Chabner BA and Wilson W: Reversal of multidrug resistance: J Clin Oncol 9: 4-6, 1991.
3. Hamada HE, Okochi T, Oh-hara T and Tsuruo T: Purification of the Mr 22,000 calcium-binding protein (sorcin)-associated with multidrug resistance and its detection with monoclonal antibodies. Cancer Res 48: 3173-3178, 1988.
4. Bucana CD, Giavazzi R, Nayar R, O'Brian CA, Seid C and Fan D: Retention of vital dyes correlates inversely with the multidrug resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Exp Cell Res 190: 69-75, 1990.
5. Baskin F, Rosenberg RN and Dev V: Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci USA 78: 3654-3658, 1981.
6. Thiebaut F, Hanauske AR and Von Hoff DD: Evidence for binding of extrachromosomal DNA sequences to nuclear matrix proteins in multidrug-resistant KM-V1 cells. FEBS Lett 319: 133-137, 1993.
7. Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD and Goldenberg GJ: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res 48: 3595-3602, 1988.
8. Fan D, Fidler IJ, Ward NE, Seid C, Earnest LE, Housey GM and O'Brian CA: Stable expression of a cDNA encoding rat brain protein kinase C-β1 confers a multidrug-resistance phenotype on rat fibroblasts. Anticancer Res 12: 661-668, 1992.
9. Pastan I and Gottesman MM: Multiple drug resistance in human cancer. N Engl J Med 28: 1388-1393, 1987.
10. Van der Bliek AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF, Hamilton TC, Joenje H and Borst P: Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 48: 5927-5932, 1988.
11. Chin K-V, Pastan I and Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 157-180, 1993.
12. Endicott JA and Ling V: The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
13. Biedler JL: Drug resistance: genotype versus phenotype: Thirty-second G.H.A. Clowes Memorial Award Lecture. Cancer Res 54: 666-678, 1994.
14. Croop JM, Gros P and Housman DE: Genetics of multidrug resistance. J Clin Invest 81: 1303-1309, 1988.
15. Bradley G, Juranka PF and Ling V: Mechanism of multidrug resistance. Biochim Biophys Acta 948: 87-128, 1988.
16. Weinstein RS, Kusczak JR, Kluskens LF and Coon JS: P-glycoproteins in pathology: the multidrug resistance gene family in humans. Hum Pathol 21: 34-48, 1990.
17. Ford JM and Hait WN: Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 42: 155-199, 1990.
18. Morrow CS and Cowan KH: Mechanisms and clinical significance of multidrug resistance. Oncology 2: 55-63, 1988.
19. Dalton WS and Grogan TM: Does P-glycoprotein predict response to chemotherapy, and if so, is there a reliable way to detect it? J Natl Cancer Inst 83: 80-81, 1991.
20. Graham CH, Kobayashi H, Stankiewicz KS, Man S, Kapitain SJ and Kerbel RS: Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst 86: 975-979, 1994.
21. Staroselsky A, Fan D, O'Brian CA, Gupta KP and Fidler IJ: Site-dependent differences in response of the UV-2237 murine fibrosarcoma to systemic therapy with adriamycin. Cancer Res 50: 7775-7780, 1990.
22. Wilmanns C, Fan D, O'Brian CA, Radinsky R, Bucana CD, Tsan R and Fidler IJ: Modulation of doxorubicin sensitivity and level of P-glycoprotein expression in human colon carcinoma cells by ectopic and orthotopic environments in nude mice. Int J Oncol 3: 412-422, 1993.
23. Wilmanns C, Fan D, O'Brian CA, Bucana CD and Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52: 98-104, 1992.
24. Dong Z, Radinsky R, Fan D, Tsan R, Bucana CD, Wilmanns C and Fidler IJ: Organ-specific modulation of steady-state mdr-1 gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst 86: 913-920, 1994.
25. Roninson I, Patel MC, Lee I, Noonan KE, Chen C-J, Choi K, Chin JE, Kaplan R and Tsuruo T: Molecular mechanism and diagnostics of multidrug resistance in human tumor cells: Cancer Cells 7: 81-87, 1989.
26. Mizoguchi T, Yamada K, Furukawa T, Hidaka K, Hisatsugu T, Shimazu H, Tsuruo T, Sumizawa T and Akiyama S: Expression of the MDR1 gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 82: 1679-1683, 1990.
27. Verrelle P, Meissonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R and Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst 83: 111-116, 1991.
28. Axiotis CA, Monteagudo C, Merino MJ, LaPorte N, and Neumann RD: Immunohistochemical detection of P-glycoprotein in endometrial adenocarcinoma. Am J Pathol 138: 799-806, 1991.
29. Weinstein RS, Jakate SM, Dominguez JM, Lebovitz MD, Koukoulis GK, Kuszak JR, Klusens LF, Grogan TM, Saclarides TJ, Roninson IB and Coon JS: Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 51: 2720-2726, 1991.
30. Arceci RJ, Stieglitz K, Bras J, Schinkel A, Baas F and Croop J: Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Cancer Res 53: 310-317, 1993.
31. Xie B, Bucana CD and Fidler IJ: Density-dependent induction of 92-kD type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am J Pathol 144: 1058-1067, 1994.
32. Corbett TH, Griswold DPJ, Roberts BJ, Peckham JC and Schabel FMJ: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays with a note on carcinogen structure. Cancer Res 35: 2434-2439, 1975.
33. Schackert HK and Fidler IJ: Development of an animal model to study the biology of recurrent colorectal cancer originating from mesenteric lymph system metastases: Int J Cancer 44: 177-181, 1989.
34. Fan D, Poste G, Ruffolo RR Jr, Dong Z, Seid C, Earnest LE, Campbell TE, Clyne RK, Beltran PJ and Fidler IJ: Circumvention of multidrug resistance in murine fibrosarcoma and colon carcinoma cells by treatment with the α-adrenoceptor antagonist furobenzazepine. Int J Oncol 4: 789-798, 1994.
35. Kartner N, Evernden-Porelle D, Bradley G and Ling V: Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature 316: 820-823, 1985.
36. Krishan A: Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol 66: 188-193, 1975.
37. Radinsky R, Kraemer PM, Raines MA, Kung H-J and Culp LA: Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression. Proc Natl Acad Sci USA 84: 5143-5147, 1987.
38. Gros P, Croop J and Housman D: Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380, 1986.
39. Raymond M, Rose E, Housman DE and Gros P: Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol 10: 1642-1651, 1990.
40. Fort P, Marty L, Liechaczyk M, Sabrouty SE, Dani C and Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphatide-hydrogenase multigene family. Nucleic Acids Res 13: 1431-1442, 1985.
41. Feinberg AP and Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-14, 1983.
42. Bucana CD, Radinsky R, Dong Z, Sanchez R, Brigati DJ and Fidler IJ: A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr1 in mouse colon carcinoma cells. J Histochem Cytochem 41: 499-506, 1993.
43. Radinsky R, Bucana CD, Ellis LM, Sanchez R, Cleary KR, Brigati DJ and Fidler IJ: A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinoma: Cancer Res 53: 937-943, 1993.
44. 30 probe. J Pathol 158: 279-286, 1989.
45. Pearson WR and Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85: 2444-2448, 1988.
46. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti G and Cantiello HF: The multidrug resistance (mdr-1) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90: 312-316, 1993.
47. Reisin I, Prat LAG, Abraham EH, Amara JF, Gregory RJ, Ausiello DA and Cantiello HF: The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J Biol Chem 269: 20584-20591, 1994.
48. Piwnica-Worms D, Rao VV, Kronauge JF and Croop JM: Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 34: 12210-12220, 1995.
49. Grossman HB, Liebert M, Lee IW and Lee SW: Decreased connexin expression and intercellular communication in human bladder cancer cells. Cancer Res 54: 3062-3065, 1994.
50. Lee CH, Bradley G, Zhang JT and Ling V: Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 157: 392-402, 1993.
51. Schuetz JD and Schuetz EG: Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes: Cell Growth Different 4: 31-40, 1993.
52. Chambers TC, McAvoy EM, Jacobs JW and Eilon G: Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679-7686, 1990.
53. Yurkow EJ and Kim G: Effects of chromium on basal and insulin-induced tyrosine phosphorylation in H4 hepatoma cells: comparison with phorbol-12-myristate-13-acetate and sodium orthovanadate. Mol Pharmacol 47: 686-695, 1995.
54. Kohno K, Sato S, Takano H, Matsuo K and Kuwano M: The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165: 1415-1421, 1989.
55. Chaudhary PM and Roninson IB: Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85: 632-639, 1993.
56. Tanimura H, Kohno K, Sato S, Uchiumi T, Miyazaki T, Kobayashi M and Kuwano M: The human multidrug resistance 1 promoter has an clement that responds to serum starvation: Biochem Biophys Res Commun 183: 917-924, 1992.
57. Miyazaki M, Kohno K, Uchiumi T, Tanimura H, Matsuo K, Nasu M and Kuwano M: Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem Biophys Res Commun 187: 677-684, 1992.
58. Uchiumi T, Kohno K, Tanimura H, Matsuo K, Sato S, Uchida Y and Kuwano M: Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Different 4: 147-157, 1993.
59. Merkel DE, Fuguga SAW, Hill SM and McGuire WL: P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer. Prog Clin Biol Res 276: 61-73, 1989.
60. Park JG, Kramer BS, Lai S, Goldstein LJ and Gazdar AF: Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. J Natl Cancer Inst 82: 193-198, 1990.
61. Williams GM, Stromberg K and Kroes R: Cytochemical and ultrastructural alterations associated with confluent growth in cell cultures of epithelial-like cells from rat liver. Lab Invest 29: 293-303, 1973.
62. Mulder KM: Differential regulation of c-myc and transforming growth factor-α messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state. Cancer Res 51: 2256-2262, 1991.
63. Gleiberman AS, Sharovskaya YY and Chailakhjan LM: Contact inhibition of alpha-fetoprotein synthesis and junctional communication in adult mouse hepatocyte culture. Exp Cell Res 184: 228-234, 1989.
64. Nagasaki T, Chapin CJ and Gundersen GG: Distribution of detyrosinated microtubules in motile NRK fibroblasts is rapidly altered upon cell-cell contact: implication for contact inhibition of locomotion. Cell Motil Cytoskeleton 23: 45-60, 1992.
65. Ralph D, McClelland M and Welsh J: RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cell growth arrested by transforming growth factor beta 1. Proc Natl Acad Sci USA 90: 10710-10714, 1993.
66. Mioszewska JP, Janik P and Szaniawska B: Phorbol binding and enzymatic activity of protein kinase C from C3H 10T1/2 cells and relation to contact inhibition. Folia Biol 37: 145-155, 1991.
67. Muller C, Laurent G and Ling V: P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J Cell Physiol 163: 538-544, 1995.
68. Singh RK, Llansa N, Bucana CD, Sanchez R, Koura A and Fidler IJ: Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells. Cell Growth Different 7: 397-404, 1996.
69. Horio M, Gottesman MM and Pastan I: ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85: 3580-3584, 1988.
70. Desoize B, Briois F and Carpentier Y: Reversion of resistance to adriamycin by vanadate on four Friend cell sublines. Int J Oncol 5: 87-91, 1994.
71. McClean S and Hill BT: Evidence of post-translational regulation of P-glycoprotein associated with the expression of a distinct multiple drug-resistant phenotype in Chinese hamster ovary cells. Eur J Cancer 29A: 2243-2248, 1993.
72. McClean S, Whelan RDH, Hosking LK, Hodges GM, Thompson FH, Meyers MB, Schuurhuis GJ and Hill BT: Characterization of the P-glycoprotein over-expressing drug resistance phenotype exhibited by Chinese hamster ovary cells following their in vitro exposure to fractionated X-irradiation. Biochim Biophys Acta 1177: 117-126, 1993.
73. Chabner BA and Fojo A: multidrug resistance: P-glycoprotein and its allies - the elusive foes. J Natl Cancer Inst 81: 910-913, 1989.
74. Bradley G, Sharma R, Rajalakshmi S and Ling V: P-glycoprotein expression during tumor progression in the rat liver. Cancer Res 52: 5154-5161, 1992.